BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 13130517)

  • 1. Overexpression of amyloid precursor protein is associated with degeneration, decreased viability, and increased damage caused by neurotoxins (prostaglandins A1 and E2, hydrogen peroxide, and nitric oxide) in differentiated neuroblastoma cells.
    Hanson AJ; Prasad JE; Nahreini P; Andreatta C; Kumar B; Yan XD; Prasad KN
    J Neurosci Res; 2003 Oct; 74(1):148-59. PubMed ID: 13130517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of alpha-synuclein decreased viability and enhanced sensitivity to prostaglandin E(2), hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells.
    Prasad JE; Kumar B; Andreatta C; Nahreini P; Hanson AJ; Yan XD; Prasad KN
    J Neurosci Res; 2004 May; 76(3):415-22. PubMed ID: 15079871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
    Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
    J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellularly generated amyloid-beta peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells.
    Esposito L; Gan L; Yu GQ; Essrich C; Mucke L
    J Neurochem; 2004 Dec; 91(6):1260-74. PubMed ID: 15584903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells.
    Zhang J; Mori A; Chen Q; Zhao B
    Neuroscience; 2006 Nov; 143(1):63-72. PubMed ID: 16962711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines.
    Lahiri DK; Lewis S; Farlow MR
    J Neurosci Res; 1994 Apr; 37(6):777-87. PubMed ID: 8046778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amyloid peptides on serum withdrawal-induced cell differentiation and cell viability.
    Wang YP; Wang ZF; Zhang YC; Tian Q; Wang JZ
    Cell Res; 2004 Dec; 14(6):467-72. PubMed ID: 15625013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region.
    Ge YW; Ghosh C; Song W; Maloney B; Lahiri DK
    J Neurochem; 2004 Sep; 90(6):1432-44. PubMed ID: 15341527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site.
    Flood F; Murphy S; Cowburn RF; Lannfelt L; Walker B; Johnston JA
    Biochem J; 2005 Jan; 385(Pt 2):545-50. PubMed ID: 15473868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.
    Irizarry MC; Deng A; Lleo A; Berezovska O; Von Arnim CA; Martin-Rehrmann M; Manelli A; LaDu MJ; Hyman BT; Rebeck GW
    J Neurochem; 2004 Sep; 90(5):1132-43. PubMed ID: 15312168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels.
    Liron T; Seraya CB; Ish-Shalom M; Souroujon MC; Neumann D
    Neuroscience; 2007 Apr; 146(1):152-9. PubMed ID: 17321053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mevastatin induces degeneration and decreases viability of cAMP-induced differentiated neuroblastoma cells in culture by inhibiting proteasome activity, and mevalonic acid lactone prevents these effects.
    Kumar B; Andreatta C; Koustas WT; Cole WC; Edwards-Prasad J; Prasad KN
    J Neurosci Res; 2002 Jun; 68(5):627-35. PubMed ID: 12111853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
    Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
    Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
    Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
    FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
    Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms.
    Karelson E; Fernaeus S; Reis K; Bogdanovic N; Land T
    J Neurosci Res; 2005 Feb; 79(3):368-74. PubMed ID: 15614786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic reticulum chaperones inhibit the production of amyloid-beta peptides.
    Hoshino T; Nakaya T; Araki W; Suzuki K; Suzuki T; Mizushima T
    Biochem J; 2007 Mar; 402(3):581-9. PubMed ID: 17132139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the APP promoter in Alzheimer's disease: cell type-specific expression of the beta-amyloid precursor protein.
    Lahiri DK; Ge YW
    Ann N Y Acad Sci; 2004 Dec; 1030():310-6. PubMed ID: 15659812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.